126 related articles for article (PubMed ID: 14981374)
1. Prospective randomized controlled trial of fetal fibronectin on preterm labor management in a tertiary care center.
Lowe MP; Zimmerman B; Hansen W
Am J Obstet Gynecol; 2004 Feb; 190(2):358-62. PubMed ID: 14981374
[TBL] [Abstract][Full Text] [Related]
2. Fetal fibronectin and bacterial vaginosis are associated with preterm birth in women who are symptomatic for preterm labor.
Stevens AO; Chauhan SP; Magann EF; Martin RW; Bofill JA; Cushman JL; Morrison JC
Am J Obstet Gynecol; 2004 Jun; 190(6):1582-7; discussion 1587-9. PubMed ID: 15284741
[TBL] [Abstract][Full Text] [Related]
3. Pregnancy outcome in women with preterm labor symptoms without cervical change.
Rinehart BK; Terrone DA; Isler CM; Barrilleaux PS; Bufkin L; Morrison JC
Am J Obstet Gynecol; 2001 Apr; 184(5):1004-7. PubMed ID: 11303212
[TBL] [Abstract][Full Text] [Related]
4. Does fetal fibronectin use in the diagnosis of preterm labor affect physician behavior and health care costs? A randomized trial.
Grobman WA; Welshman EE; Calhoun EA
Am J Obstet Gynecol; 2004 Jul; 191(1):235-40. PubMed ID: 15295372
[TBL] [Abstract][Full Text] [Related]
5. Assessment of rapid fetal fibronectin in predicting preterm delivery.
Tekesin I; Marek S; Hellmeyer L; Reitz D; Schmidt S
Obstet Gynecol; 2005 Feb; 105(2):280-4. PubMed ID: 15684152
[TBL] [Abstract][Full Text] [Related]
6. [Economical impact of preterm delivery management based on fetal fibronectin results].
García Alonso LA; Ayala Méndez JA; Jiménez Solís G; Aguilar Gutiérrez F; Díaz Cueto L
Ginecol Obstet Mex; 2004 Aug; 72():385-93. PubMed ID: 15526554
[TBL] [Abstract][Full Text] [Related]
7. Performance of cervicovaginal fetal fibronectin in a community hospital setting.
Incerti M; Ghidini A; Korker V; Pezzullo JC
Arch Gynecol Obstet; 2007 May; 275(5):347-51. PubMed ID: 17051404
[TBL] [Abstract][Full Text] [Related]
8. Clinical utility of fetal fibronectin for predicting preterm birth.
Swamy GK; Simhan HN; Gammill HS; Heine RP
J Reprod Med; 2005 Nov; 50(11):851-6. PubMed ID: 16419634
[TBL] [Abstract][Full Text] [Related]
9. A randomized multicenter study to determine the efficacy of activity restriction for preterm labor management in patients testing negative for fetal fibronectin.
Elliott JP; Miller HS; Coleman S; Rhea D; Abril D; Hallbauer K; Istwan NB; Stanziano GJ
J Perinatol; 2005 Oct; 25(10):626-30. PubMed ID: 16107874
[TBL] [Abstract][Full Text] [Related]
10. Improved management in threatened preterm labour with rapid fetal fibronectin testing.
Parry E; Singh TG; Dow D; Noovao F
Aust N Z J Obstet Gynaecol; 2006 Jun; 46(3):240-1. PubMed ID: 16704480
[TBL] [Abstract][Full Text] [Related]
11. Fetal fibronectin.
Koenn ME
Clin Lab Sci; 2002; 15(2):96-8, 115. PubMed ID: 12776771
[TBL] [Abstract][Full Text] [Related]
12. Negative fetal fibronectin: who is still treating for threatened preterm labor and does it help?
Peláez LM; Fox NS; Chasen ST
J Perinat Med; 2008; 36(3):202-5. PubMed ID: 18576928
[TBL] [Abstract][Full Text] [Related]
13. [Is fetal fibronectin a valid test predictive of premature labor?].
Mansouri A; Tadjerouni A; El Rabiey G; Baube S; Garnier G; Tribalat S
Contracept Fertil Sex; 1997 May; 25(5):380-4. PubMed ID: 9273109
[TBL] [Abstract][Full Text] [Related]
14. "Blind" vaginal fetal fibronectin as a predictor of spontaneous preterm delivery.
Roman AS; Koklanaris N; Paidas MJ; Mulholland J; Levitz M; Rebarber A
Obstet Gynecol; 2005 Feb; 105(2):285-9. PubMed ID: 15684153
[TBL] [Abstract][Full Text] [Related]
15. The efficacy of fetal fibronectin testing in minimising hospital admissions, length of hospital stay and cost savings in women presenting with symptoms of pre-term labour.
Dutta D; Norman JE
J Obstet Gynaecol; 2010; 30(8):768-73. PubMed ID: 21126111
[TBL] [Abstract][Full Text] [Related]
16. Fetal fibronectin--how useful is it in the prediction of preterm birth?
Leitich H; Kaider A
BJOG; 2003 Apr; 110 Suppl 20():66-70. PubMed ID: 12763115
[TBL] [Abstract][Full Text] [Related]
17. Vaginal fetal fibronectin as a predictor of spontaneous preterm delivery after multifetal pregnancy reduction.
Roman AS; Rebarber A; Lipkind H; Mulholland J; Minior V; Roshan D
Am J Obstet Gynecol; 2004 Jan; 190(1):142-6. PubMed ID: 14749650
[TBL] [Abstract][Full Text] [Related]
18. A randomised controlled trial of metronidazole for the prevention of preterm birth in women positive for cervicovaginal fetal fibronectin: the PREMET Study.
Shennan A; Crawshaw S; Briley A; Hawken J; Seed P; Jones G; Poston L
BJOG; 2006 Jan; 113(1):65-74. PubMed ID: 16398774
[TBL] [Abstract][Full Text] [Related]
19. Fetal fibronectin test predicts delivery before 30 weeks of gestation in high risk women, but increases anxiety.
Shennan A; Jones G; Hawken J; Crawshaw S; Judah J; Senior V; Marteau T; Chinn S; Poston L
BJOG; 2005 Mar; 112(3):293-8. PubMed ID: 15713142
[TBL] [Abstract][Full Text] [Related]
20. Fetal fibronectin: the impact of a rapid test on the treatment of women with preterm labor symptoms.
Plaut MM; Smith W; Kennedy K
Am J Obstet Gynecol; 2003 Jun; 188(6):1588-93; discussion 1593-5. PubMed ID: 12824997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
